Cleared Traditional

K834301 - THROMBOLYTIC ACTIVITY TEST

K834301 is the FDA 510(k) clearance for THROMBOLYTIC ACTIVITY TEST by Bio/Data Corp.. It is a Class 2 Hematology device (product code GJA) cleared through the Traditional 510(k) pathway after a 57-day FDA review.

K834301 · Bio/Data Corp. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1984
Decision
57d
Days
Class 2
Risk

K834301 is an FDA 510(k) clearance for the THROMBOLYTIC ACTIVITY TEST. Classified as Test, Thrombin Time (product code GJA), Class II - Special Controls.

Submitted by Bio/Data Corp. (Mchenry, US). The FDA issued a Cleared decision on February 4, 1984 after a review of 57 days - a notably fast clearance cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.7875 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Bio/Data Corp. devices

Submission Details

510(k) Number K834301 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 09, 1983
Decision Date February 04, 1984
Days to Decision 57 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
56d faster than avg
Panel avg: 113d · This submission: 57d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GJA Test, Thrombin Time
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.7875
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GJA Test, Thrombin Time

All 16
Devices cleared under the same product code (GJA) and FDA review panel - the closest regulatory comparables to K834301.
FIBRI-PREST/THROMBIN-PREST CONTROLS
K884385 · American Bioproducts Co. · Dec 1988
IL SYSTEM 810, ACL AND THE REAGENT SETS
K862301 · Instrumentation Laboratory CO · Sep 1986
THROMBINEX BOVINE THROMBIN
K845000 · Bio/Data Corp. · Mar 1985
THROMBIN TIME TEST
K822466 · American Dade · Sep 1982
THROMBIN CLOTTING TIME
K811109 · Bio/Data Corp. · Jul 1981
FIBRI QUIK
K802117 · General Diagnostics · Sep 1980